Intermittent Claudication
📧 Sign up to get email alerts when something new happens for Intermittent Claudication.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2008-08-21Clinical Trial Update: PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients [Phase 3]
Phase 3 PROVIDENCE-1 trial of rifalazil in Chlamydia pneumoniae seropositive patients with peripheral vascular disease or intermittent claud…
-
CLINICAL_TRIALS trial_result · 2008-07-15Clinical Trial Update: PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents [Phase 4]
A Phase 4 trial comparing angioplasty (PTA) versus primary stenting of the superficial femoral artery using self-expandable nitinol stents i…
-
FDA approval · 2008-06-27FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for cilostazol filed by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS research · 2008-05-09Clinical Trial Update: (Cost) Effectiveness Study of Exercise Therapy in Patients With Peripheral Arterial Disease [NA]
Update on a cost-effectiveness study of exercise therapy for patients with peripheral artery disease presenting intermittent claudication; c…
-
CLINICAL_TRIALS trial_result · 2008-04-28Clinical Trial Update: Angioplasty in Peripheral Arterial Disease and Endothelial Function [Phase 4]
This Phase 4 clinical trial update evaluates angioplasty for peripheral arterial obstructive disease and its effect on endothelial function;…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-04-28Clinical Trial Update: Exercise for Elderly Peripheral Revascularized Patients [NA]
This completed clinical trial, led by the National Institute on Aging, studied an exercise program in elderly patients who had undergone per…
-
CLINICAL_TRIALS trial_result · 2008-04-09Clinical Trial Update: Exercise Rehabilitation of Younger and Older People With Claudication [NA]
The clinical trial evaluating exercise rehabilitation for intermittent claudication has completed.
-
FDA approval · 2008-03-10FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)
FDA approves Chartwell RX, LLC's supplemental application for cilostazol (generic) under ANDA077021, enabling market authorization for a gen…
-
FDA approval · 2008-03-10FDA Approved: CILOSTAZOL — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for cilostazol filed by Chartwell RX, LLC.
-
CLINICAL_TRIALS trial_result · 2007-11-22Clinical Trial Update: Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease [Phase 2]
This update notes the completion of a Phase 2 trial evaluating VLTS-934 for intermittent claudication due to peripheral artery disease.
-
CLINICAL_TRIALS trial_result · 2007-08-31Clinical Trial Update: Dacron vs Dardik for Fem-Pop Bypass [Phase 3]
Phase 3 trial comparing Dacron and Dardik vascular grafts for femoropopliteal bypass has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-21Clinical Trial Update: Balloon Angioplasty vs. Cutting Balloon Angioplasty of Femoropopliteal Arteries- a Randomized Controlled Trial [Phase 4]
Phase 4 randomized trial comparing Balloon Angioplasty to Cutting Balloon Angioplasty in the femoropopliteal arteries was terminated.
-
FDA approval · 2007-01-12FDA Approved: PENTOXIFYLLINE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for Pentoxifylline submitted by Rising Pharma Holdings, Inc., enabling continued marketing of th…
-
FDA approval · 2006-12-07FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Cilostazol submitted by Teva Pharmaceuticals USA, Inc., related to the approved Cilostazol p…
-
CLINICAL_TRIALS trial_result · 2006-11-02Clinical Trial Update: The Dose Response of Niacin ER/Lovastatin on Peak Walking Time (PWT) in Patients With Intermittent Claudication - TROPIC [Phase 3]
Phase 3 trial update assessing the dose response of niacin extended-release and lovastatin on peak walking time in patients with intermitten…
-
CLINICAL_TRIALS trial_result · 2006-11-01Clinical Trial Update: Effect of Niacin ER/Lovastatin on Peak Walking Time & Claudication Onset Time in Patients With Intermittent Claudication [Phase 3]
Phase 3 clinical trial evaluating the Niacin ER/Lovastatin combination on peak walking time and claudication onset time in patients with int…
-
CLINICAL_TRIALS trial_result · 2006-10-18Clinical Trial Update: Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease [Phase 2]
Phase 2 efficacy study evaluating oral L-Citrulline in patients taking simvastatin with peripheral arterial disease (intermittent claudicati…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Extract of Ginkgo Biloba (EGB 761) and Vascular Function [Phase 1, Phase 2]
A completed Phase 1/Phase 2 study evaluating EGb 761 Ginkgo biloba extract for vascular function in intermittent claudication and peripheral…
-
CLINICAL_TRIALS trial_result · 2006-05-19Clinical Trial Update: Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication [Phase 2]
Phase 2 trial assessing the efficacy and safety of NM-702 tablets for intermittent claudication; the study has completed.
-
FDA approval · 2006-05-08FDA Approved: CILOSTAZOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved Teva's supplemental application for cilostazol (generic) under ANDA077027.